|Bid||407.70 x 800|
|Ask||407.96 x 800|
|Day's Range||402.44 - 408.85|
|52 Week Range||253.86 - 475.35|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||59.71|
|Earnings Date||Oct 28, 2021|
|Forward Dividend & Yield||0.68 (0.17%)|
|Ex-Dividend Date||Jul 20, 2021|
|1y Target Est||436.00|
Subscribe to Yahoo Finance Plus to view Fair Value for WSTLearn more
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […]
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2021 financial results before the market opens on Thursday, October 28, 2021, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 5587559.
West Pharmaceutical (WST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.